2024
DOI: 10.47739/2379-089x.drugdesign.1095
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility and Effective Binding Inhibitors against COVID-19 BA.2.86

Toshihiko Hanai

Abstract: The binding strength of COVID-19 variants, Omicron BQ.1, XBB.1.5, XBB 1.16, FE.1, EG.5, and BA.2.86, with the ACE-2, was calculated and evaluated with previous variants.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 24 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?